Cellular Context Dictates the Suppression or Augmentation of Triple-Negative Mammary Tumor Metastasis by NLRX1

Author:

Nagai-Singer Margaret A.1ORCID,Woolls Mackenzie K.1ORCID,Leedy Katerina1ORCID,Hendricks-Wenger Alissa2ORCID,Brock Rebecca M.2ORCID,Coutermarsh-Ott Sheryl1ORCID,Paul Tamalika1ORCID,Morrison Holly A.1ORCID,Imran Khan M.2ORCID,Tupik Juselyn D.1,Fletcher Endia J.3ORCID,Brown David A.4ORCID,Allen Irving C.1ORCID

Affiliation:

1. *Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA

2. †Graduate Program in Translational Biology, Medicine and Health, Virginia Tech, Roanoke, VA

3. ‡Postbaccalaureate Research Education Program, Virginia Tech, Blacksburg, VA

4. §Stealth BioTherapeutics, Needham, MA

Abstract

Abstract Prior studies have defined multiple, but inconsistent, roles for the enigmatic pattern recognition receptor NLRX1 in regulating several cancer-associated biological functions. In this study, we explore the role of NLRX1 in the highly metastatic murine 4T1 mammary tumor model. We describe a functional dichotomy of NLRX1 between two different cellular contexts: expression in healthy host cells versus expression in the 4T1 tumor cells. Using Nlrx1−/− mice engrafted with 4T1 tumors, we demonstrate that NLRX1 functions as a tumor suppressor when expressed in the host cells. Specifically, NLRX1 in healthy host cells attenuates tumor growth and lung metastasis through suppressing characteristics of epithelial–mesenchymal transition and the lung metastatic niche. Conversely, we demonstrate that NLRX1 functions as a tumor promoter when expressed in 4T1 tumor cells using gain- and loss-of-function studies both in vitro and in vivo. Mechanistically, NLRX1 in the tumor cells augments 4T1 aggressiveness and metastasis through regulating epithelial–mesenchymal transition hallmarks, cell death, proliferation, migration, reactive oxygen species levels, and mitochondrial respiration. Collectively, we provide critical insight into NLRX1 function and establish a dichotomous role of NLRX1 in the 4T1 murine mammary carcinoma model that is dictated by cellular context.

Funder

HHS | NIH | National Cancer Institute

HHS | NIH | National Institute of Biomedical Imaging and Bioengineering

VT | Virginia-Maryland College of Veterinary Medicine

VT | Institute for Critical Technologies and Applied Science, Virginia Tech

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Focus on negatively regulated NLRs in inflammation and cancer;International Immunopharmacology;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3